Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JWVX | ISIN: US30303M1027 | Ticker-Symbol: FB2A
Tradegate
21.01.25
21:52 Uhr
591,10 Euro
-0,50
-0,08 %
1-Jahres-Chart
META PLATFORMS INC Chart 1 Jahr
5-Tage-Chart
META PLATFORMS INC 5-Tage-Chart
RealtimeGeldBriefZeit
592,10592,7021.01.
590,90592,6021.01.
ACCESS Newswire
206 Leser
Artikel bewerten:
(1)

Meta: How Open Source AI Is Evolving Healthcare

Finanznachrichten News

NORTHAMPTON, MA / ACCESS Newswire / January 21, 2025 / Takeaways

  • Open source AI is transforming healthcare outcomes by enabling important innovations in medical technology and healthcare research.

  • Researchers have used models like Llama to improve the accuracy of radiological diagnostic tools, match patients with clinical trials and more.

  • With more equitable health outcomes estimated to lead to nearly $3 trillion in GDP growth, open source AI drives economic growth as well as healthcare innovation.

Open source AI models like Llama are available for free for organizations to use, modify and build on, making this critical technology more accessible than commercial models.

As a result, open source is enabling important innovations in medical technology, healthcare research and related sectors, helping researchers make crucial advancements to solve intractable problems.

Developers, researchers and other professionals can download and fine-tune the models on their own devices. That they don't need to send their data back to the AI model providers strengthens control and security over private health data - critical factors for highly regulated industries like healthcare. The stakes here are not only scientific but economic, with improved health outcomes across communities estimated to add $2.8 trillion to US GDP by 2040.

Here are a few stories from companies who are using Llama's open source technology to create a healthier future.

Zauron Labs

Zauron Labs's Guardian AI double-checks radiological imaging exams and reports to find errors, helping to improve healthcare outcomes. "People don't realize that there are around 3 billion medical imaging exams done per year with a 3-5% error rate," says radiologist Dr. Kal Clark. "That's millions of patients."

When such errors occur, proper treatments can be delayed, illness and suffering can linger, and patients may experience worse long-term health outcomes. Open source AI models have the potential to substantially reduce those errors.

"With Meta's Llama, we're able to collaborate with universities and build the Guardian AI tool to double check for errors. It's like a spell checker for radiologists," says Dr. Clark, Vice Chair of Informatics at University of Texas Health San Antonio and co-founder of Zauron Labs.

Llama has enabled Zauron Labs to open up development across health systems, so that developers can "layer on" multiple algorithms to check for numerous medical issues at once as part of regular quality and safety exercises, amplifying the tool's usefulness for patients and practitioners.

Mendel

Mendel's Hypercube is an AI platform that helps health and science organizations draw insights from patient data using a chat-like tool built on open source AI, including Llama.

Applications for Hypercube include trial matching and patient cohorting, which are important: around 80% of clinical trials fail to meet their enrollment targets today, slowing the discovery of new treatments. "Studies have shown that it takes hundreds of days to match patients with a clinical trial. Hypercube can do it in one day," says Dr. Wael Salloum, Founder and Chief Science Officer at Mendel.

Open source AI gives companies access to what Dr. Salloum calls "breakthrough technology." "Using Meta's open source AI, Llama, Hypercube allows health care companies to organize their data on their own cloud, creating a secure and searchable knowledge base." adds Dr. Salloum.

With Llama, Mendel's Hypercube can be used to extract reliable information from patient records at scale.

View additional multimedia and more ESG storytelling from Meta on 3blmedia.com.

Contact Info:
Spokesperson: Meta
Website: https://www.3blmedia.com/profiles/meta
Email: info@3blmedia.com

SOURCE: Meta



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.